Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Dietary change could be a key to enhancing colon cancer treatment

A dietary change could be a key to enhancing colon cancer treatment, a new study from the University of Michigan Rogel Cancer Center finds.

20 Nov 2022

Study finds a positive impact of exercise on the gut microbiome of cancer patients

Regular physical activity can extend colorectal cancer patients' lives. In a first-ever study, scientists looked at the impact of exercise on the gut microbiome of cancer patients and reported a positive association.

14 Nov 2022

Researchers discover residual tumor cells responsible for colon cancer relapse

Colon cancer is the third most common cancer in the world, with about 2 million new cases each year. Most patients are diagnosed when the tumor is still located in the colon or rectum.

9 Nov 2022

Lower risk of colorectal cancer associated with dietary flavanone and anthocyanidin intake, according to new research

In a new study, researchers assessed the risk of colorectal cancer (CRC) with the intake of flavonoids.

31 Oct 2022

Piceatannol and mTOR inhibitor combination proves be an attractive therapeutic strategy for gastric cancer

This study is led by Dr. Longtao Huangfu, and Dr. Xiaoyang Wang (Peking University Cancer Hospital & Institute). A diet of fresh fruits and vegetables may reduce the prevalence of cancers, including GC (Eusebi et al., 2020; Liu et al., 2021).

28 Oct 2022

Overall cancer death rates continue to decline in the United States, says Annual Report to the Nation

Overall cancer death rates continued to decline among men, women, children, and adolescents and young adults in every major racial and ethnic group in the United States from 2015 to 2019, according to the latest Annual Report to the Nation on the Status of Cancer. From 2014 to 2018, overall cancer incidence, or new cases of cancer, remained stable for men and children but increased for women and adolescents and young adults.

28 Oct 2022

Research reveals a differential clinical response to pembrolizumab in uterine cancer patients

New research from Yale Cancer Center reveals for the first time ever a differential clinical response to pembrolizumab in Lynch-like (mutated) vs methylated microsatellite instability-high (MSI-H) uterine cancer patients, increasing our understanding about the proportion of patients that derive benefit from immune checkpoint blockade.

28 Oct 2022

Commensal gut microbes from IBD patients produce genotoxic metabolites

Functional screening of human gut microbiota reveals a family of small molecule genotoxins called indolimines in patients with inflammatory bowel disease (IBD), according to a new study.

27 Oct 2022

Research opens up new avenues for overcoming treatment resistance in colorectal cancer

Colorectal cancer is one of the most common cancers. Its treatment is mainly based on chemotherapy. However, over time, chemotherapy induces resistance in the majority of patients, who end up being unresponsive to the drugs.

27 Oct 2022

Metabolite product from pomegranate improves the function of immune cells to fight against cancer

As part of an interdisciplinary project of the LOEWE Centre Frankfurt Cancer Institute (FCI), researchers from the Georg-Speyer-Haus in Frankfurt am Main, Germany, and Goethe University Frankfurt have succeeded in identifying a new approach for the therapy of colorectal cancer.

27 Oct 2022

Henry Ford Hospital earns three-year accreditation from National Accreditation Program for Rectal Cancer

Henry Ford Hospital has earned a three-year accreditation from the National Accreditation Program for Rectal Cancer (NAPRC), which was developed through a collaboration between the OSTRiCh (Optimizing the Surgical Treatment of Rectal Cancer) consortium and the Commission on Cancer, a quality program of the American College of Surgeons.

20 Oct 2022

Common oral bacterium promotes tumor progression-associated activity in pancreatic cancer cells

Virginia Tech researchers from the Department of Biomedical Engineering and Mechanics and the Department of Biochemistry have discovered a characteristic of a common oral bacterium that relocates to pancreatic cancer tumors that may help guide future therapeutic interventions for treatment.

18 Oct 2022

Fecal immunochemical test and mt-sDNA test are equally effective for colorectal cancer screening

Commercially available noninvasive screening tests for colorectal cancer - a fecal immunochemical test (FIT) and the multi-target stool DNAtest (mt-sDNA; or Cologuard®) - are equally effective for screening patients with early-stage colorectal cancer.

17 Oct 2022

Study finds highlight the potential for lowering rehabilitation utilization for colorectal patients

The first months of the COVID pandemic had a profound effect on hospital discharge practices and use patterns for patients with colorectal disease, according to findings presented at the Scientific Forum of the American College of Surgeons Clinical Congress 2022.

17 Oct 2022

More frequent chest imaging may benefit certain colorectal cancer patients

Colorectal cancer patients with certain clinical characteristics may benefit from more frequent chest imaging to help identify and target cancer that has spread to the lungs, according to new research presented at the Scientific Forum of the American College of Surgeons (ACS) Clinical Congress 2022.

17 Oct 2022

Certain types of dietary fiber fuel inflammation in some people with inflammatory bowel disease

People who suffer from inflammatory bowel disease may soon have access to personalized dietary guidelines to keep them feeling well, thanks to new research on how dietary fibre affects the disease.

13 Oct 2022

Colonoscopy-screening less effective to prevent patients from dying from colorectal cancer

On October 10 the world's first randomized study on using colonoscopy-screening to prevent colorectal cancer was presented during the 2022 UEG Week in Vienna.

11 Oct 2022

Review on COVID-19 biomedical waste-derived microplastic toxicity

In a new study, researchers reviewed existing literature on the biomedical waste source, elements, and the recent upsurge of microplastics during the SARS-CoV-2 pandemic.

11 Oct 2022

Study reveals an increase in the prevalence of digestive diseases

Data from a new pan-European study on the burden of digestive diseases, presented today at UEG Week 2022 and published in the United European Gastroenterology Journal, highlights a worrying increase in the prevalence of several digestive diseases since 2000. These include chronic liver diseases, pancreatitis, gastroesophageal reflux disease, gastritis, vascular intestinal disorders and coeliac disease in children. In addition, the incidence and mortality rates for all digestive cancers combined have increased by 26% and 17% respectively in the period 2000-2019.

10 Oct 2022

Disparities in cancer screening rates associated with U.S. county's social vulnerability index

Populations in U.S. counties defined as more vulnerable based on social factors including socioeconomic status and racial/ethnic minority status were significantly less likely to receive timely breast, cervical, and colorectal cancer screenings, according to research from UTHealth Houston.

27 Sep 2022

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Dietary change could be a key to enhancing colon cancer treatment

Study finds a positive impact of exercise on the gut microbiome of cancer patients

Researchers discover residual tumor cells responsible for colon cancer relapse

Lower risk of colorectal cancer associated with dietary flavanone and anthocyanidin intake, according to new research

Piceatannol and mTOR inhibitor combination proves be an attractive therapeutic strategy for gastric cancer

Overall cancer death rates continue to decline in the United States, says Annual Report to the Nation

Research reveals a differential clinical response to pembrolizumab in uterine cancer patients

Commensal gut microbes from IBD patients produce genotoxic metabolites

Research opens up new avenues for overcoming treatment resistance in colorectal cancer

Metabolite product from pomegranate improves the function of immune cells to fight against cancer

Henry Ford Hospital earns three-year accreditation from National Accreditation Program for Rectal Cancer

Common oral bacterium promotes tumor progression-associated activity in pancreatic cancer cells

Fecal immunochemical test and mt-sDNA test are equally effective for colorectal cancer screening

Study finds highlight the potential for lowering rehabilitation utilization for colorectal patients

More frequent chest imaging may benefit certain colorectal cancer patients

Certain types of dietary fiber fuel inflammation in some people with inflammatory bowel disease

Colonoscopy-screening less effective to prevent patients from dying from colorectal cancer

Review on COVID-19 biomedical waste-derived microplastic toxicity

Study reveals an increase in the prevalence of digestive diseases

Disparities in cancer screening rates associated with U.S. county's social vulnerability index

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in